Understanding The Potential Drug Target DIXDC1 (G85458)

Target Name: DIXDC1

NCBI ID: G85458

DIXDC1

Understanding The Potential Drug Target DIXDC1

DIXDC1, also known as Coiled-coil-DIX1, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the DIX family of proteins, which are known for their role in intracellular signaling. While the exact function of DIXDC1 is not yet fully understood, research has shown that it to be involved in a variety of physiological processes, including cell signaling, inflammation, and regeneration.

Drug Targeting

DIXDC1 has been identified as a potential drug target due to its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these conditions makes it an attractive target for small molecule inhibitors, which can be used to treat these diseases.

One of the key challenges in targeting DIXDC1 is its complex structure. DIXDC1 is a transmembrane protein that consists of an extracellular region, a coiled-coil region, and an intracellular region. The coiled-coil region is the most well-studied part of the protein, and its structure are key factors.

One of the most well-known structures of DIXDC1 is the alpha-helices, which are highly conserved regions that are involved in the protein's stability and functions. These regions are involved in the formation of the protein's alpha-helices, which are important for the protein's stability and functions.

Another well-known structure of DIXDC1 is the interaction with other proteins. DIXDC1 has been shown to interact with several proteins, including the protein Taiping, which is a key regulator of the DNA damage response. This interaction between DIXDC1 and Taiping suggests that DIXDC1 may play a role in the regulation of cellular processes, including DNA damage response.

Biomarker

DIXDC1 has also been shown to be involved in several biological processes, including cell signaling and inflammation. Its involvement in these processes makes it an attractive biomarker for a variety of diseases.

One of the most well-known applications of DIXDC1 as a biomarker is its involvement in cancer. DIXDC1 has been shown to be involved in the regulation of cell signaling, which is a key factor in the development and progression of cancer.

Another application of DIXDC1 as a biomarker is its involvement in neurodegenerative diseases. DIXDC1 has been shown to be involved in the regulation of neurotransmitter release and synaptic plasticity, which are important factors in the development and progression of neurodegenerative diseases.

Another application of DIXDC1 as a biomarker is its involvement in autoimmune disorders. DIXDC1 has been shown to be involved in the regulation of immune cell function, which is a key factor in the development and progression of autoimmune disorders.

Conclusion

In conclusion, DIXDC1 is a protein that is involved in a variety of physiological processes, including cell signaling, inflammation, and regeneration. Its complex structure and interaction with other proteins make it an attractive target for small molecule inhibitors. Furthermore, its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders makes it an attractive biomarker for these diseases. Further research is needed to fully understand the functions of DIXDC1 and its potential as a drug target.

Protein Name: DIX Domain Containing 1

Functions: Positive effector of the Wnt signaling pathway; activates WNT3A signaling via DVL2. Regulates JNK activation by AXIN1 and DVL2

The "DIXDC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DIXDC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets